Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.14M | 1.29M | 650.60K | 4.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.38B | 1.14M | 1.29M | 650.60K | 4.92M |
| Cost of Revenue | 62.40K | 57.10K | 58.30K | -975.50K | 1.37M |
| Gross Profit | 1.38B | 1.08M | 1.24M | 1.63M | 3.56M |
| SG&A Expenses | 16.80M | 14.51M | 22.01M | 13.82M | 11.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 26.60M | 3.04M | -448.30K | 462.30K | -- |
| Total Operating Expenses | 114.06M | 58.56M | 57.91M | 52.14M | 43.55M |
| Operating Income | 1.27B | -57.42M | -56.61M | -51.49M | -38.62M |
| Income Before Tax | 1.23B | -47.50M | -41.67M | -39.46M | -42.43M |
| Income Tax Expenses | 81.73M | -194.10K | -82.00K | -202.60K | -189.90K |
| Earnings from Continuing Operations | 1.15B | -47.30M | -41.59M | -39.26M | -42.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.15B | -47.30M | -41.59M | -39.26M | -42.24M |
| EBIT | 1.27B | -57.42M | -56.61M | -51.49M | -38.62M |
| EBITDA | 1.27B | -56.58M | -56.24M | -50.58M | -37.65M |
| EPS Basic | 16.29 | -0.67 | -0.59 | -0.56 | -0.67 |
| Normalized Basic EPS | 10.90 | -0.44 | -0.38 | -0.38 | -0.44 |
| EPS Diluted | 16.06 | -0.67 | -0.59 | -0.56 | -0.67 |
| Normalized Diluted EPS | 10.75 | -0.44 | -0.38 | -0.38 | -0.44 |
| Average Basic Shares Outstanding | 70.73M | 70.60M | 70.74M | 70.66M | 62.69M |
| Average Diluted Shares Outstanding | 71.71M | 70.60M | 70.74M | 70.66M | 62.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |